The stock of KP Tissue Inc (TSE:KPT) is a huge mover today! About 20,157 shares traded hands or 94.25% up from the average. KP Tissue Inc (TSE:KPT) has risen 19.62% since April 27, 2016 and is uptrending. It has outperformed by 13.69% the S&P500.
The move comes after 6 months positive chart setup for the $149.06M company. It was reported on Dec, 1 by Barchart.com. We have $16.55 PT which if reached, will make TSE:KPT worth $5.96M more.
KP Tissue Inc (TSE:KPT) Ratings Coverage
Out of 4 analysts covering KP Tissue (TSE:KPT), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. $18 is the highest target while $13.50 is the lowest. The $16.50 average target is 3.71% above today’s ($15.91) stock price. KP Tissue has been the topic of 18 analyst reports since August 13, 2015 according to StockzIntelligence Inc. As per Friday, October 21, the company rating was downgraded by TD Securities. The firm has “Hold” rating by TD Securities given on Friday, November 4. The rating was maintained by TD Securities on Friday, August 12 with “Buy”. The company was upgraded on Monday, November 28 by RBC Capital Markets. The rating was maintained by Scotia Capital with “Outperform” on Tuesday, September 1. The stock of KP Tissue Inc (TSE:KPT) has “Outperform” rating given on Thursday, November 24 by Scotia Capital. The company was maintained on Friday, November 4 by Scotia Capital.
KP Tissue Inc. is created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. . The company has a market cap of $149.06 million. KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom tissue, facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets. It currently has negative earnings. KPLP operates through three divisions: consumer products sold through traditional retail channels, such as grocery stores, mass merchandisers, club stores, drug stores and convenience stores (Consumer); AFH, and Other.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.